References
1. Rickinson AB. Co-infections, inflammation and oncogenesis: future directions for EBV research. Semin Cancer Biol. 2014;26:99-115.
2. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res. 2004;10(3):803-21.
3. Rezk SA, Weiss LM. Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol. 2007;38(9):1293-304.
4. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer. 2006;6(3):193-203.
5. Behrns KE, Sarr MG, Strickler JG. Pancreatic Lymphoma: Is It a Surgical Disease? Pancreas. 1994;9(5):662-7.
6. Alvaro F, Jain M, Morris LL, et al. Childhood acute lymphoblastic leukaemia presenting as jaundice. J Paediatr Child Health. 1996;32(5):466-8.
7. Shimamura R, Ishibashi H, Morioka E, et al. Assessment of abdominal involvement of adult T-cell leukemia/lymphoma by ultrasonography: comparison among four clinical types. J Clin Ultrasound. 1991;19(8):485-92.
8. Siddique MN, Popalzai M, Aoun N, et al. Precursor B-cell acute lymphoblastic leukemia presenting as obstructive jaundice: a case report. J Med Case Rep. 2011;5:269.
9. Mori T, Sugita K-i, Suzuki T, et al. Histopathologic features of the biopsied liver at onset of childhood B-precursor acute lymphoblastic leukemia presenting as severe jaundice. Journal of pediatric gastroenterology and nutrition. 1997;25(3):354-7.
10. Devictor D, Tahiri C, Fabre M, et al. Early pre-B acute lymphoblastic leukemia presenting as fulminant liver failure. Journal of pediatric gastroenterology and nutrition. 1996;22(1):103-6.
11. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. The Lancet. 2013;381(9881):1943-55.
12. Vallacha A, Haider G, Raja W, et al. Remission rate of acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYA). Journal of the College of Physicians and Surgeons Pakistan. 2018;28(2):118-22.
13. Ward E, DeSantis C, Robbins A, et al. Childhood and adolescent cancer statistics, 2014. CA: a cancer journal for clinicians. 2014;64(2):83-103.
14. Litten JB, Rodríguez MM, Maniaci V. Acute lymphoblastic leukemia presenting in fulminant hepatic failure. Pediatric blood & cancer. 2006;47(6):842-5.
15. Heincelman M, Karakala N, Rockey DC. Acute lymphoblastic leukemia in a young adult presenting as hepatitis and acute kidney injury. Journal of investigative medicine high impact case reports. 2016;4(3):2324709616665866.
16. Ödemiş B, Parlak E, Başar Ö, et al. Biliary Tract Obstruction Secondary to Malignant Lymphoma: Experience at a Referral Center. Digestive Diseases and Sciences. 2007;52(9):2323-32.
17. Kader A, Vara R, Egberongbe Y, et al. Leukaemia presenting with fulminant hepatic failure in a child. European journal of pediatrics. 2004;163(10):628-9.
18. Kelleher JF, Monteleone PM, Steele DA, et al. Hepatic dysfunction as the presenting feature of acute lymphoblastic leukemia. Journal of pediatric hematology/oncology. 2001;23(2):117-21.
19. Rajesh G, Sadasivan S, Hiran K, et al. Acute myeloid leukemia presenting as obstructive jaundice. Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology. 2006;25(2):93-4.
20. Comeau TB, Phillips DL. Chemotherapy dosing with elevated liver function test results in acute leukemia. Annals of Pharmacotherapy. 2005;39(10):1752-4.
21. Takamatsu T. Preferential infiltration of liver sinusoids in acute lymphoblastic leukemia. [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology. 2001;42(12):1181-6.
22. Schäfer G, Blumenthal MJ, Katz AA. Interaction of human tumor viruses with host cell surface receptors and cell entry. Viruses. 2015;7(5):2592-617.
23. Straus SE, Cohen JI, Tosato G, et al. Epstein-Barr virus infections: biology, pathogenesis, and management. Annals of internal medicine. 1993;118(1):45-58.
24. Lu Y, Sun L-R, Pang X-Y, et al. Infection status and clinical significance of Epstein-Barr virus in pediatric leukemia—a report of 35 cases. Ai Zheng= Aizheng= Chinese Journal of Cancer. 2007;26(1):54-7.
25. Sehgal S, Mujtaba S, Gupta D, et al. High incidence of Epstein Barr virus infection in childhood acute lymphocytic lukemia: A preliminary study. Indian journal of pathology and microbiology. 2010;53(1):63.
26. Young LS, Rickinson AB. Epstein–Barr virus: 40 years on. Nature Reviews Cancer. 2004;4(10):757-68.
27. Parkin DM. The global health burden of infection‐associated cancers in the year 2002. International journal of cancer. 2006;118(12):3030-44.
28. Ateyah ME, Hashem ME, Abdelsalam M. Epstein–Barr virus and regulatory T cells in Egyptian paediatric patients with acute B lymphoblastic leukaemia. Journal of Clinical Pathology. 2017;70(2):120-5.
29. Cohen JI. Epstein–Barr virus infection. New England journal of medicine. 2000;343(7):481-92.
30. Williams H, Crawford DH. Epstein-Barr virus: the impact of scientific advances on clinical practice. Blood. 2006;107(3):862-9.
31. Lehtinen M, Koskela P, Ögmundsdottir HM, et al. Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring. American journal of epidemiology. 2003;158(3):207-13.
32. Ahmed HG, Osman SI, Ashankyty IM. Incidence of Epstein-Barr Virus in Pediatric Leukemia in the Sudan. Clinical Lymphoma Myeloma and Leukemia. 2012;12(2):127-31.
33. Loutfy SA, El-Din HA, Ibrahim MF, et al. Seroprevalence of herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus in children with acute lymphoblastic leukemia in Egypt. Saudi medical journal. 2006;27(8):1139.
34. Mahjour SB, Ghaffarpasand F, Fattahi MJ, et al. Seroprevalence of human herpes simplex, hepatitis B and epstein-barr viruses in children with acute lymphoblastic leukemia in southern iran. Pathology & Oncology Research. 2010;16(4):579-82.